Organon & Co. Statistics
Total Valuation
Organon & Co. has a market cap or net worth of $3.79 billion. The enterprise value is $11.78 billion.
Important Dates
The last earnings date was Thursday, October 31, 2024, before market open.
| Earnings Date | Oct 31, 2024 |
| Ex-Dividend Date | Nov 12, 2024 |
Share Statistics
Organon & Co. has 257.54 million shares outstanding. The number of shares has increased by 0.92% in one year.
| Current Share Class | 257.54M |
| Shares Outstanding | 257.54M |
| Shares Change (YoY) | +0.92% |
| Shares Change (QoQ) | +0.45% |
| Owned by Insiders (%) | 0.23% |
| Owned by Institutions (%) | 81.31% |
| Float | 256.70M |
Valuation Ratios
The trailing PE ratio is 2.92 and the forward PE ratio is 3.77. Organon & Co.'s PEG ratio is 0.78.
| PE Ratio | 2.92 |
| Forward PE | 3.77 |
| PS Ratio | 0.59 |
| Forward PS | 0.58 |
| PB Ratio | 7.69 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 5.08 |
| P/OCF Ratio | 4.01 |
| PEG Ratio | 0.78 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 6.68, with an EV/FCF ratio of 15.77.
| EV / Earnings | 9.05 |
| EV / Sales | 1.84 |
| EV / EBITDA | 6.68 |
| EV / EBIT | 7.83 |
| EV / FCF | 15.77 |
Financial Position
The company has a current ratio of 1.70, with a Debt / Equity ratio of 17.75.
| Current Ratio | 1.70 |
| Quick Ratio | 0.89 |
| Debt / Equity | 17.75 |
| Debt / EBITDA | 4.78 |
| Debt / FCF | 11.71 |
| Interest Coverage | 2.91 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 7.91% |
| Return on Capital (ROIC) | 10.86% |
| Revenue Per Employee | $640,900 |
| Profits Per Employee | $130,100 |
| Employee Count | 10,000 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 2.08 |
Taxes
| Income Tax | -519.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +30.24% in the last 52 weeks. The beta is 0.80, so Organon & Co.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.80 |
| 52-Week Price Change | +30.24% |
| 50-Day Moving Average | 17.82 |
| 200-Day Moving Average | 19.27 |
| Relative Strength Index (RSI) | 26.24 |
| Average Volume (20 Days) | 3,202,203 |
Short Selling Information
The latest short interest is 14.15 million, so 5.49% of the outstanding shares have been sold short.
| Short Interest | 14.15M |
| Short Previous Month | 9.77M |
| Short % of Shares Out | 5.49% |
| Short % of Float | 5.51% |
| Short Ratio (days to cover) | 6.54 |
Income Statement
In the last 12 months, Organon & Co. had revenue of $6.41 billion and earned $1.30 billion in profits. Earnings per share was $5.04.
| Revenue | 6.41B |
| Gross Profit | 3.73B |
| Operating Income | 1.50B |
| Pretax Income | 655.00M |
| Net Income | 1.30B |
| EBITDA | 1.76B |
| EBIT | 1.50B |
| Earnings Per Share (EPS) | $5.04 |
Full Income StatementBalance Sheet
The company has $763.00 million in cash and $8.75 billion in debt, giving a net cash position of -$7.99 billion or -$31.01 per share.
| Cash & Cash Equivalents | 763.00M |
| Total Debt | 8.75B |
| Net Cash | -7.99B |
| Net Cash Per Share | -$31.01 |
| Equity (Book Value) | 493.00M |
| Book Value Per Share | 1.91 |
| Working Capital | 1.97B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $946.00 million and capital expenditures -$199.00 million, giving a free cash flow of $747.00 million.
| Operating Cash Flow | 946.00M |
| Capital Expenditures | -199.00M |
| Free Cash Flow | 747.00M |
| FCF Per Share | $2.90 |
Full Cash Flow StatementMargins
Gross margin is 58.26%, with operating and profit margins of 23.47% and 20.30%.
| Gross Margin | 58.26% |
| Operating Margin | 23.47% |
| Pretax Margin | 12.20% |
| Profit Margin | 20.30% |
| EBITDA Margin | 27.52% |
| EBIT Margin | 23.47% |
| FCF Margin | 13.47% |
Dividends & Yields
This stock pays an annual dividend of $1.12, which amounts to a dividend yield of 7.60%.
| Dividend Per Share | $1.12 |
| Dividend Yield | 7.60% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 22.22% |
| Buyback Yield | -0.92% |
| Shareholder Yield | 6.68% |
| Earnings Yield | 34.30% |
| FCF Yield | 19.69% |
Dividend DetailsAnalyst Forecast
The average price target for Organon & Co. is $21.33, which is 44.81% higher than the current price. The consensus rating is "Hold".
| Price Target | $21.33 |
| Price Target Difference | 44.81% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | -0.04% |
| EPS Growth Forecast (5Y) | 0.75% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Organon & Co. has an Altman Z-Score of 1.41 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.41 |
| Piotroski F-Score | 4 |